Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2013 Aug 14;8(8):e70867.
doi: 10.1371/journal.pone.0070867. eCollection 2013.

IgA and neutralizing antibodies to influenza a virus in human milk: a randomized trial of antenatal influenza immunization

Elizabeth P Schlaudecker  1 , Mark C Steinhoff, Saad B Omer, Monica M McNeal, Eliza Roy, Shams E Arifeen, Caitlin N Dodd, Rubhana Raqib, Robert F Breiman, K Zaman
Affiliations
Randomized Controlled Trial

IgA and neutralizing antibodies to influenza a virus in human milk: a randomized trial of antenatal influenza immunization

Elizabeth P Schlaudecker et al. PLoS One. .

Abstract

Background: Antenatal immunization of mothers with influenza vaccine increases serum antibodies and reduces the rates of influenza illness in mothers and their infants. We report the effect of antenatal immunization on the levels of specific anti-influenza IgA levels in human breast milk. (ClinicalTrials.gov identifier NCT00142389; http://clinicaltrials.gov/ct2/show/NCT00142389).

Methods and findings: The Mother's Gift study was a prospective, blinded, randomized controlled trial that assigned 340 pregnant Bangladeshi mothers to receive either trivalent inactivated influenza vaccine, or 23-valent pneumococcal polysaccharide vaccine during the third trimester. We evaluated breast milk at birth, 6 weeks, 6 months, and 12 months, and serum at 10 weeks and 12 months. Milk and serum specimens from 57 subjects were assayed for specific IgA antibody to influenza A/New Caledonia (H1N1) using an enzyme-linked immunosorbent assay (ELISA) and a virus neutralization assay, and for total IgA using ELISA. Influenza-specific IgA levels in breast milk were significantly higher in influenza vaccinees than in pneumococcal controls for at least 6 months postpartum (p = 0.04). Geometric mean concentrations ranged from 8.0 to 91.1 ELISA units/ml in vaccinees, versus 2.3 to 13.7 ELISA units/mL in controls. Virus neutralization titers in milk were 1.2 to 3 fold greater in vaccinees, and correlated with influenza-specific IgA levels (r = 0.86). Greater exclusivity of breastfeeding in the first 6 months of life significantly decreased the expected number of respiratory illness with fever episodes in infants of influenza-vaccinated mothers (p = 0.0042) but not in infants of pneumococcal-vaccinated mothers (p = 0.4154).

Conclusions: The sustained high levels of actively produced anti-influenza IgA in breast milk and the decreased infant episodes of respiratory illness with fever suggest that breastfeeding may provide local mucosal protection for the infant for at least 6 months. Studies are needed to determine the cellular and immunologic mechanisms of breast milk-mediated protection after antepartum immunization.

Trial registration: ClinicalTrials.gov NCT00142389.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: MCS reports receiving research support from Wyeth and Sanofi-Aventis for other studies and lecture fees from GlaxoSmithKline, Aventis Pasteur, and Sanofi-Aventis. This study was also partly funded by Aventis Pasteur. Fluarix is a GlaxoSmithKline product, but this product was purchased directly from the manufacturer with no funding support from GlaxoSmithKline. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.

Figures

Figure 1
Figure 1. CONSORT study diagram.
Of the 340 women randomized to receive influenza vaccine or pneumococcal vaccine, breast milk samples from 57 women were analyzed for IgA antibody and neutralizing activity.
Figure 2
Figure 2. Geometric mean adjusted influenza-specific IgA in breast milk in influenza versus control vaccines.
Geometric mean adjusted influenza-specific IgA antibody is significantly higher in the breast milk of influenza vaccinees compared to control vaccinees for at least 6 months postpartum.
Figure 3
Figure 3. Geometric mean neutralization titers in serum in influenza versus control vaccines.
Geometric mean anti-influenza neutralization titers are significantly higher in the serum of influenza vaccinees compared to control vaccinees at delivery.
See this image and copyright information in PMC

References

    1. Glezen WP, Paredes A, Taber LH (1980) Influenza in children. Relationship to other respiratory agents. JAMA 243: 1345–1349. - PubMed
    1. Poehling KA, Edwards KM, Weinberg GA, Szilagyi P, Staat MA, et al. (2006) The underrecognized burden of influenza in young children. N Engl J Med 355: 31–40. - PubMed
    1. Henkle E, Steinhoff MC, Omer SB, Roy E, Arifeen SE, et al. (2010) Incidence of Influenza Virus Infection in Early Infancy: a Prospective Study in South Asia. Pediatr Infect Dis J 30: 170–3. - PubMed
    1. Brooks WA, Goswami D, Rahman M, Nahar K, Fry AM, et al. (2010) Influenza is a major contributor to childhood pneumonia in a tropical developing country. Pediatr Infect Dis J 29: 216–221. - PubMed
    1. Schlaudecker EP, Heck JP, Macintyre ET, Martinez R, Dodd CN, et al. (2012) Etiology and Seasonality of Viral Respiratory Infections in Rural Honduran Children. Pediatr Infect Dis J 31: 1113–8. - PMC - PubMed

Publication types

Associated data